Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART ...

Funding to fight HIV among gay and bisexual men and transgender women is a fraction of what it should be, researchers said on Tuesday, with advocates blaming stigma for the shortfall.

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

Some lawmakers and advocates are increasingly uncertain whether critical HIV and AIDS services will survive the federal government’s funding fight. The GOP’s House-passed budget bill seeks to cut ...

SPOKANE, Wash. – The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the approval, Dr. Rachel Safran was part of an original ...

ICIs are safe and effective for HIV-positive NSCLC patients, with no significant differences in survival outcomes compared to ...

A University of Massachusetts public health researcher has received four grants totaling $17.9 million from the National Institutes of Health to launch three projects that will build on existing ...

High stigma levels correlate with lower ART adherence and viral suppression in women with HIV, especially those who inject drugs. The study used data from the WIHS, focusing on stigma's impact on HIV ...

It found that across the 34 emergency departments taking part in the programme, 3,667 people were newly diagnosed with ...

Currently available medications could be enough to end the HIV epidemic in the United States, provided people can access and afford them, experts have said. Taken as directed, modern medications can ...

Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...